ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Revenue Cycle Optimizations Among Nextech Enhancements on Display at AAD 2025

TAMPA, Fla., March 07, 2025 (GLOBE NEWSWIRE) -- Nextech, the leader in healthcare technology and practice management solutions for specialty providers, today announced it will preview the latest enhancements to its 2025 Best in KLAS®-winning technology platform at the American Academy of Dermatology (AAD) Annual Meeting, held March 7-11 in Orlando, Fla. Nextech's recently launched revenue cycle management (RCM) professional billing services will be among the new advancements in the spotlight at AAD 2025.

"Managing a practice’s revenue cycle has never been more complex, with evolving payer requirements and increasing claim denials creating significant challenges for providers," said David Metcalfe, Chief Technology Officer at Nextech. "With Nextech RCM, we’re providing specialty practices with integrated, intelligent solutions that streamline billing workflows, reduce administrative burden, and help maximize reimbursement — so providers can focus on delivering exceptional patient care."

Insurance claim denials have steadily risen in recent years, impacting cash flow, increasing administrative burdens, and creating operational inefficiencies for providers. Nextech RCM is designed to alleviate these challenges and make it easier for providers to salvage denied claims and increase their reimbursement.

RCM is fully integrated within Nextech's specialty-specific platform and includes a comprehensive package of services that can be customized to suit an individual practice's needs and priorities, whether that’s sending unpaid patient responsibility to collections or executing on a patient payment plan.

AAD attendees who visit Booth 2113 will have access to experience Nextech RCM and other enhancements to the company's dermatology-specific platform and see why it is a two-time winner of the Best in KLAS: Ambulatory Specialty EHR and AAD’s only DataDerm™ Gold Recognition EHR.

To learn more about how Nextech enables specialty providers to improve the health and well-being of the communities they serve, visit www.nextech.com.

About Nextech
Nextech is the complete healthcare technology solution for specialty providers. Since 1997, Nextech has been focused on delivering innovative solutions and services that drive efficiency, fuel growth, and enhance the patient care experience. Nextech services more than 16,000 physicians and over 60,000 office staff members in the clinical specialties of dermatology, med spa, ophthalmology, orthopedics, and plastic surgery.

Jenna Paulus
Director of Corporate Communications
j.paulus@nextech.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.22
+21.36 (9.58%)
AAPL  270.37
-1.03 (-0.38%)
AMD  256.12
+1.28 (0.50%)
BAC  53.45
+0.42 (0.79%)
GOOG  281.82
-0.08 (-0.03%)
META  648.35
-18.12 (-2.72%)
MSFT  517.81
-7.95 (-1.51%)
NVDA  202.49
-0.40 (-0.20%)
ORCL  262.61
+5.72 (2.23%)
TSLA  456.56
+16.46 (3.74%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.